MarketCap
Facebook
X
Telegram
FONAR Corporation Market Cap | FONR
As of October 25, 2026 FONAR Corporation has a market cap of $ 140 M
Capitalization is the market value of a company whose shares are traded on the stock exchange. It is calculated by multiplying the market price of a share by the total number of the company's shares. Capitalization indicates volatility, risk, and growth potential. This metric is often used for a quick assessment of a company’s investment profile.[1]
Capitalization is an important indicator for investors and analysts, as it helps determine the size and significance of a company in the stock market. Companies with large capitalization are considered more stable and reliable, as they have more resources and financial power to grow and survive in the market.
This metric can be divided into several categories: small (from 300 million to 2 billion dollars), medium (from 2 to 10 billion dollars), and large (over 10 billion dollars). Companies with different levels of capitalization have their own characteristics and risks, so investors usually take this indicator into account when making investment decisions.
Capitalization can also change over time depending on the share price and the number of shares in circulation. Therefore, it is a dynamic indicator that requires constant monitoring and analysis to make well-informed investment decisions.
Annual Market Cap FONAR Corporation
| 2025 | 2024 | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 | 2017 | 2016 | 2015 | 2014 | 2013 | 2012 | 2011 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| - | - | - | 89.5 M | 91.1 M | 158 M | 154 M | 163 M | 170 M | 144 M | 64.3 M | 68 M | 35.5 M | 20.3 M | 10.4 M |
Annual performance
Select metrics to display
All numbers in USD currency
Indicator range from annual reports
| Maximum | Minimum | Average |
|---|---|---|
| 170 M | 10.4 M | 97.4 M |
References
- Pavone, P. (2019). Market capitalization and financial variables: Evidence from Italian listed companies. International Journal of Academic Research Business and Social Sciences, 9(3), 1356-1371.
Market Cap of other stocks in the Medical devices industry
| Issuer | Market Cap | Price | % 24h | Market Cap | Country | |
|---|---|---|---|---|---|---|
 |
Orthofix Medical
OFIX
|
491 M | $ 9.81 | -1.8 % | $ 388 M |  Curacao |
 |
TransMedics Group
TMDX
|
4.69 B | $ 70.74 | -1.83 % | $ 2.4 B |  USA |
 |
Abbott Laboratories
ABT
|
196 B | $ 103.7 | 1.17 % | $ 181 B | USA |
 |
Electromed
ELMD
|
325 M | $ 26.37 | -1.86 % | $ 218 M | USA |
 |
Align Technology
ALGN
|
12.9 B | $ 154.51 | -0.64 % | $ 11.2 B | USA |
 |
InMode Ltd.
INMD
|
928 M | $ 13.97 | -0.57 % | $ 903 M |  Israel |
 |
Nevro Corp.
NVRO
|
213 M | - | - | $ 217 M | USA |
 |
Inspire Medical Systems
INSP
|
1.76 B | $ 71.11 | -2.13 % | $ 2.09 B | USA |
 |
Apyx Medical Corporation
APYX
|
142 M | $ 2.37 | -1.66 % | $ 97.4 M | USA |
 |
IRIDEX Corporation
IRIX
|
16.6 M | $ 0.75 | -2.18 % | $ 12.7 M | USA |
 |
IRadimed Corporation
IRMD
|
1.25 B | $ 85.82 | -2.08 % | $ 1.09 B | USA |
 |
Accuray Incorporated
ARAY
|
31.9 M | $ 0.13 | -2.91 % | $ 15.9 M | USA |
 |
Aethlon Medical
AEMD
|
1.36 M | $ 5.05 | -2.7 % | $ 3.4 M | USA |
 |
Venus Concept
VERO
|
1.84 M | - | - | $ 726 K | USA |
 |
LENSAR
LNSR
|
71.3 M | $ 6.07 | 0.83 % | $ 72.6 M | USA |
 |
Alphatec Holdings
ATEC
|
2.07 B | $ 11.11 | -2.2 % | $ 1.67 B | USA |
 |
Eargo
EAR
|
17 M | - | - | $ 10.2 M | USA |
 |
Medtronic PLC
MDT
|
102 B | $ 95.41 | -1.18 % | $ 122 B | USA |
 |
Sientra
SIEN
|
20.9 M | - | -16.59 % | $ 10.3 M | USA |
 |
AxoGen
AXGN
|
1.5 B | $ 38.06 | 3.76 % | $ 1.75 B | USA |
 |
Silk Road Medical, Inc
SILK
|
683 M | - | - | $ 1.07 B | USA |
 |
Myomo
MYO
|
33.9 M | $ 1.21 | -0.82 % | $ 50.6 M | USA |
 |
Surgalign Holdings
SRGA
|
11.4 M | - | -32.98 % | $ 1.68 M | USA |
 |
ShockWave Medical
SWAV
|
9.61 B | - | - | $ 12.3 B | USA |
 |
Bio-Rad Laboratories
BIO
|
5.9 B | $ 369.95 | 1.68 % | $ 10.1 B | USA |
 |
Abiomed
ABMD
|
16.2 M | - | - | $ 17.2 B | USA |
 |
Titan Medical
TMDI
|
115 M | - | -26.32 % | $ 19.6 M |  Canada |
 |
Natus Medical Incorporated
NTUS
|
799 M | - | 1.94 % | $ 1.05 B | USA |
 |
Cardiovascular Systems
CSII
|
602 M | - | 0.15 % | $ 844 M | USA |
 |
Outset Medical
OM
|
52.5 K | $ 4.1 | -1.68 % | $ 62.4 K | USA |
 |
Bruker Corporation
BRKR
|
5.58 B | $ 57.59 | 0.49 % | $ 8.74 B | USA |
 |
Boston Scientific Corporation
BSX
|
113 B | $ 45.69 | -0.7 % | $ 67.6 B | USA |
 |
Inari Medical
NARI
|
3.07 B | - | - | $ 4.23 B | USA |
 |
Allied Healthcare Products
AHPI
|
5.38 M | - | 3.58 % | $ 2.21 M | USA |
 |
PAVmed
PAVM
|
5.81 M | $ 2.17 | 5.85 % | $ 1.45 M | USA |
 |
Insulet Corporation
PODD
|
18.1 B | $ 149.01 | 0.6 % | $ 10.5 B | USA |
 |
Profound Medical Corp.
PROF
|
166 M | $ 5.56 | -3.47 % | $ 168 M | Canada |
 |
AVITA Medical
RCEL
|
104 M | $ 15.51 | 0.58 % | $ 432 M |  Australia |
 |
Avinger
AVGR
|
2.59 M | - | -20.74 % | $ 369 K | USA |
 |
Apollo Endosurgery
APEN
|
403 M | - | - | $ 475 M | USA |
 |
NuVasive
NUVA
|
2.29 B | - | - | $ 2.07 B | USA |
 |
Butterfly Network
BFLY
|
946 M | $ 6.76 | -0.81 % | $ 1.67 B | USA |
 |
ClearPoint Neuro
CLPT
|
316 M | $ 9.14 | -1.19 % | $ 259 M | USA |
 |
Sintx Technologies
SINT
|
6.91 M | $ 1.58 | -3.66 % | $ 4.38 M | USA |
 |
CONMED Corporation
CNMD
|
1.32 B | $ 49.25 | -0.11 % | $ 1.53 B | USA |
 |
Smith & Nephew plc
SNN
|
27.4 B | $ 30.83 | -0.11 % | $ 26.7 B |  Britain |
 |
Sensus Healthcare
SRTS
|
72.3 M | $ 2.95 | 1.55 % | $ 48.2 M | USA |
 |
Cytosorbents Corporation
CTSO
|
34.8 M | $ 5.27 | -12.31 % | $ 328 M | USA |
 |
Axonics Modulation Technologies
AXNX
|
2.82 B | - | - | $ 3.31 B | USA |
 |
ThermoGenesis Holdings
THMO
|
2.09 M | - | -25.84 % | $ 171 K | USA |